Cannabichromene Safety in Rheumatoid Arthritis

Stopped This study was put on clinical hold with the FDA prior to beginning enrollment due to insufficient preclinical evidence.

Conditions

• Arthritis, Rheumatoid

Interventions

• DRUG: Cannabichromene

Sponsor

Crystal Lederhos Smith